R&D Abandonment in Regulatory Equilibrium: Evidence from Asset Price Shocks Induced by FDA Decisions
Publication information:
R&D Abandonment in Regulatory Equilibrium: Evidence from Asset Price Shocks Induced by FDA Decisions. 2013.
Abstract
Presenter: Dan Carpenter
Full text
Presenter: Dan Carpenter